© Provided by The Motley Fool
A man walks up three brick pillars to a dollar sign.
© Provided by The Motley Fool
A man walks up three brick pillars to a dollar sign.
Yesterday I wrote about building a portfolio with the ultimate aim of growing its value to one million dollars. You can read about that here.
Part of this involves investing $20,000 into a handful of the very best ASX 200 shares each year.
If you do this and can achieve a return greater than the long-term market average, you could theoretically grow your portfolio to the $1 million mark in 15 years.
One thing I didnât include in that article was the ASX 200 shares that I would buy with this first $20,000 investment. So, letâs do that now.
Here are two ASX 200 shares I would buy now:
I continue to believe that CSL is one of the highest-quality companies on the Australian share market. So, with the biotherapeutics giantâs shares still trading at a decent discount to their pre-COVID high, I think it could be an opportune time to invest.
Particularly given CSL’s increasingly positive outlook. The significant headwinds the company was facing with plasma collections during the pandemic have now eased, which is expected to be a big boost to its margins. Especially with the rollout of its new plasma collection technology, which has been designed to deliver greater plasma yields.
In addition, strong demand for immunoglobulins, the companyâs ongoing US$1 billion+ annual investment in research and development, and its blockbuster acquisition of Vifor Pharma appear supportive of solid growth over the coming years.
Another ASX 200 share that I would invest $20,000 into is Xero. It is a leading cloud-based accounting platform provider with 3.5 million subscribers globally.
While this is undoubtedly a large number of subscribers, it is still barely even scratching at the surface of its huge market opportunity. For example, Goldman Sachs estimates that Xero has a total addressable market of 100 million small to medium sized businesses globally.
And with the shift to the cloud still relatively early on and its platform highly regarded in the industry, Xero looks well-placed to capture a growing slice of its TAM over the next decade and beyond. I believe that this, combined with the growing revenue it earns from its app store, the stickiness of its platform, and periodic price increases, positions Xero to grow its earnings at a rapid rate over the remainder of the 2020s.
The post How Iâd invest $20k in ASX 200 shares in 2023 to aim for a million appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now…
*Returns as of February 1 2023
More reading
Motley Fool contributor James Mickleboro has positions in CSL and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.